WM Gregory
Impact in
-
- Cancer Treatment and Pharmacology
- Global Cancer Incidence and Screening
- Cancer Risks and Factors
- Bone health and treatments
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 9
- Cancer Risks and Factors 3
- HER2/EGFR in Cancer Research 2
-
- Breast Cancer Treatment Studies 6
- Co-authors
- MA Richards (3 shared papers)IS Fentiman (4 shared papers)R. Swindell (1 shared paper)RD Rubens (1 shared paper)TA Lister (1 shared paper)D Crowther (1 shared paper)ME Hill (1 shared paper)John Wagstaff (1 shared paper)
- Journals
- British Journal of Cancer (9 papers)Cancer Research (2 papers)International Journal of Gynecology & Obstetrics (1 paper)Clinical Lymphoma & Myeloma (4 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
WM Gregory
15 papers receiving 301 citations
Peers
Comparison fields: 5 of 51
- Oncology 152
- Cancer Research 82
- Pathology and Forensic Medicine 65
- Genetics 21
- Modeling and Simulation 8
Countries citing papers authored by WM Gregory
This map shows the geographic impact of WM Gregory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by WM Gregory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites WM Gregory more than expected).
Fields of papers citing papers by WM Gregory
This network shows the impact of papers produced by WM Gregory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by WM Gregory. The network helps show where WM Gregory may publish in the future.
Co-authors
The 25 scholars most cited alongside WM Gregory, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 52 | |
| 2 | 1993 | 50 | |
| 3 | 1988 | 49 | |
| 4 | 1996 | 39 | |
| 5 | 1992 | 35 | |
| 6 | 1996 | 34 | |
| 7 | 2012 | 15 | |
| 8 | 1997 | 11 | |
| 9 | 1994 | 8 | |
| 10 | 1996 | 8 | |
| 11 | 1990 | 6 | |
| 12 | 2009 | 5 | |
| 13 | 2009 | 3 | |
| 14 | 2019 | 1 | |
| 15 | 2009 | 1 | |
| 16 | 2009 | 0 |
About WM Gregory
WM Gregory is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Pharmacology, having authored 16 papers that have together received 317 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Cancer Risks and Factors (3 papers), Estrogen and related hormone effects (2 papers), Inflammatory mediators and NSAID effects (2 papers), Multiple Myeloma Research and Treatments (2 papers), Lung Cancer Treatments and Mutations (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (152 citations), Cancer Research (82 citations), Pathology and Forensic Medicine (65 citations), Genetics (21 citations) and Modeling and Simulation (8 citations). WM Gregory has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include MA Richards, IS Fentiman, R. Swindell, RD Rubens, TA Lister, D Crowther, ME Hill, John Wagstaff, Paul Smith and C.J. Twelves. Their work appears in journals such as British Journal of Cancer, Cancer Research, International Journal of Gynecology & Obstetrics and Clinical Lymphoma & Myeloma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.